Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much? (Q38322257)

2 September 2017

1 reference

title

Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much? (English)

1 reference

2 September 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597332%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Per Pfeiffer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597332%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Ursula Falkmer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597332%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Laurids Ø Poulsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597332%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Mette Yilmaz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597332%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Halfdan Sorbye

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597332%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

19 January 2015

1 reference

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597332%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597332%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597332%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

437-446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597332%20AND%20SRC:MED&resulttype=core&format=json

Estimates of the cancer incidence and mortality in Europe in 2006.

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Preoperative versus postoperative chemoradiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

SEOM clinical guidelines for the adjuvant treatment of colorectal cancer 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Chemotherapy with preoperative radiotherapy in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

A randomized trial of oral 5-fluorouracil versus placebo as adjuvant therapy in colorectal cancer Dukes' B and C: results after 5 years observation time.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Effective surgical adjuvant therapy for high-risk rectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Randomised trials of HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Potential regional differences for the tolerability profiles of fluoropyrimidines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: is it essential for patients with ypT0-2N0?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Adjuvant chemotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Mutational analysis and clinical correlation of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Gene expression differences between colon and rectum tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Colorectal cancer: a tale of two sides or a continuum?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

A comparison of colon and rectal somatic DNA alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Chromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2014.993768

10.3109/0284186X.2014.993768

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597332%20AND%20SRC:MED&resulttype=core&format=json

release_27xddggfavc6bovw2qalof2psm

31 May 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/27xddggfavc6bovw2qalof2psm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference